ZLD Zelda Partners with Ilera HealthCare 12/03/19 PRICE SENSITIVE Share ZLD Aus Patent For Novel Prognostic Marker for Breast Cancer 06/03/19 PRICE SENSITIVE Share ZLD Novel Cannabis Pathway for Treatment of Breast Cancer 28/02/19 Share ZLD Appendix 4D & FY19 Interim Financial Report 22/02/19 PRICE SENSITIVE Share ZLD Appendix 3B 19/02/19 Share ZLD Results of Meeting 18/02/19 Share ZLD ZLD Engages ICCI for Clinical Trial and Regulatory Expertise 12/02/19 Share ZLD Change of Director's Interest Notice 05/02/19 Share ZLD Appendix 4C - quarterly 30/01/19 PRICE SENSITIVE Share ZLD December 2018 Quarterly Report and Board Transition 30/01/19 PRICE SENSITIVE Share ZLD Notice of General Meeting 18/01/19 Share ZLD Appendix 3B 16/01/19 Share ZLD Response to ASX Appendix 3Y Query 16/01/19 Share ZLD Change in substantial holding 14/01/19 Share ZLD Change of Director's Interest Notice 14/01/19 Share ZLD Response to ASX Price and Volume Query 08/01/19 PRICE SENSITIVE Share ZLD Change of Director's Interest Notice 14/12/18 Share ZLD Change of Director's Interest Notice 07/12/18 Share ZLD ZLD to Invest in Development of Oral Spray Formulations 06/12/18 PRICE SENSITIVE Share ZLD SUD: SUDA Enters Agreement To Develop Cannabinoid Spray 06/12/18 PRICE SENSITIVE Share ZLD Results of Meeting 30/11/18 Share ZLD Annual General Meeting Presentation 2018 30/11/18 Share ZLD Investor Presentation - Non-deal Roadshow 27/11/18 Share ZLD Opioid reduction clinical trial with St Vincent's Hospital 26/11/18 PRICE SENSITIVE Share ZLD Appendix 3B 22/11/18 Share ZLD Correction to Unlisted Option Expiry Date 14/11/18 Share ZLD Release From Escrow and Founders Commitment Not to Sell 07/11/18 Share ZLD Appendix 4C - quarterly 31/10/18 PRICE SENSITIVE Share ZLD September 2018 Quarterly Report 31/10/18 PRICE SENSITIVE Share ZLD Notice of Annual General Meeting 29/10/18 Share ZLD Managing Director Remuneration Variation 12/10/18 Share ZLD Zelda Focuses Clinical Trial Activity 11/10/18 PRICE SENSITIVE Share ZLD US Autism Observational Study Underway 10/10/18 PRICE SENSITIVE Share ZLD First Patient Dosed in Zelda Insomnia Trial 26/09/18 PRICE SENSITIVE Share ZLD Investor Presentation - Non-deal Roadshow 25/09/18 Share ZLD Zelda Forms New Partnership to Access German Market 04/09/18 PRICE SENSITIVE Share ZLD Appendix 4G 31/08/18 Share ZLD Appendix 4E & Financial Statements 31/08/18 PRICE SENSITIVE Share ZLD Appendix 3B 22/08/18 Share ZLD Two Key Clinical Appointments to Medical Advisory Board 22/08/18 Share ZLD June 2018 Quarterly Report 30/07/18 PRICE SENSITIVE Share ZLD Appendix 4C - quarterly 30/07/18 PRICE SENSITIVE Share ZLD Initial Director's Interest Notice 16/07/18 download Created with Sketch. 30.18KB Share ZLD Commencement of New Managing Director 16/07/18 PRICE SENSITIVE download Created with Sketch. 159.29KB Share ZLD Paediatric Brain Cancer Research Update 06/06/18 download Created with Sketch. 146.6KB Share ZLD Details of Company Address 25/05/18 download Created with Sketch. 113.53KB Share ZLD Appointment of Managing Director 22/05/18 PRICE SENSITIVE download Created with Sketch. 124.53KB Share ZLD March 2018 Quarterly Report 30/04/18 PRICE SENSITIVE Share ZLD Appendix 4C - quarterly 30/04/18 PRICE SENSITIVE Share ZLD Insomnia Clinical Trial Update-Patient Recruitment Completed 23/04/18 PRICE SENSITIVE Share ZLD Research into Cannabinoids and Diabetes-Related Conditions 18/04/18 Share ZLD US Autism Observational Study Receives IRB Approval 13/04/18 Share ZLD Expansion of Pancreatic Cancer Research Programme 06/03/18 PRICE SENSITIVE Share ZLD Appendix 4D & FY18 Interim Financial Report 27/02/18 PRICE SENSITIVE Share ZLD December 2017 Quarterly Report 31/01/18 Share ZLD Appendix 4C - quarterly 31/01/18 PRICE SENSITIVE Share ZLD Shares Begin Trading in the USA on the OTCQB Venture Market 22/01/18 Share ZLD Appendix 3B 12/01/18 Share ZLD Cancellation of Unlisted Options 10/01/18 Share ZLD Change of Director's Interest Notice 20/12/17 Share ZLD Zelda joins with US Children's Hospital for autism study 11/12/17 PRICE SENSITIVE Share ZLD Trading Halt 08/12/17 PRICE SENSITIVE Share ZLD Response to ASX Aware Query 05/12/17 PRICE SENSITIVE Share ZLD Australian Regulators Approve Zelda Insomnia Clinical Trial 29/11/17 PRICE SENSITIVE Share ZLD Results of Meeting 24/11/17 Share ZLD Annual General Meeting Presentation 2017 24/11/17 Share ZLD Chairman's Address - Annual General Meeting 24/11/17 Share ZLD Response to ASX Price and Volume Query 22/11/17 PRICE SENSITIVE Share ZLD Trading Halt 21/11/17 PRICE SENSITIVE Share ZLD Appendix 3B - Release of Securities from Escrow 16/11/17 Share ZLD Release from Escrow 01/11/17 Share ZLD September 2017 Quarterly Report 31/10/17 Share ZLD Appendix 4C - quarterly 31/10/17 PRICE SENSITIVE Share ZLD Notice of Annual General Meeting 26/10/17 Share ZLD Successful Results in Autism Observation Trial 18/09/17 PRICE SENSITIVE Share ZLD Update on Closing Date of CannPal Priority Offer 18/09/17 Share ZLD Update on Research Programme in Chile 13/09/17 Share ZLD Appendix 4G 31/08/17 Share ZLD Appendix 4E & Financial Statements 31/08/17 PRICE SENSITIVE Share ZLD CannPal Priority Share Offer Clarification Announcement 31/08/17 Share ZLD Priority Share Offer for CannPal IPO Shares 29/08/17 Share ZLD Company Presentation on 2017 Half Year Activities 25/08/17 Share ZLD Expansion of Breast Cancer Research Collaboration 31/07/17 PRICE SENSITIVE Share ZLD June 2017 Quarterly Report 28/07/17 Share ZLD Appendix 4C - quarterly 28/07/17 PRICE SENSITIVE Share ZLD ENT:Acquisition of prospective Au& Cu/Zn Murchison Tenements 26/07/17 PRICE SENSITIVE Share ZLD Updated Securities Trading and Corporate Governance Policies 30/06/17 Share ZLD Zelda Enters into Strategic Agreement with Knop Laboratories 15/06/17 PRICE SENSITIVE Share ZLD Positive Results From Pre-Clinical Breast Cancer Studies 02/06/17 PRICE SENSITIVE Share ZLD March 2017 Quarterly Report 28/04/17 PRICE SENSITIVE Share ZLD Appendix 4C - quarterly 28/04/17 PRICE SENSITIVE Share ZLD Appendix 3B - Release of Securities from Escrow 21/04/17 Share ZLD Clinical Research Programme to Expand to Include Autism 19/04/17 PRICE SENSITIVE Share ZLD Change in substantial holding x 3 06/04/17 Share ZLD Appendix 3B 05/04/17 Share ZLD Release from Escrow 04/04/17 Share ZLD Cleansing Prospectus 03/04/17 PRICE SENSITIVE Share ZLD Zelda Successfully Completes Capital Raising 30/03/17 PRICE SENSITIVE Share ZLD Trading Halt 28/03/17 PRICE SENSITIVE Share ZLD Zelda Enters Strategic Partnership with CannPal 27/03/17 PRICE SENSITIVE Share
64.5¢
(20min delay)
